Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic.
about
Risk-reducing medication for primary breast cancer: a network meta-analysisFactors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysisBarriers to preventive therapy for breast and other major cancers and strategies to improve uptakePhysician and Patient Barriers to Breast Cancer Preventive TherapyAtypical epithelial hyperplasia of the breast: state of the art.Dissect the Dynamic Molecular Circuits of Cell Cycle Control through Network Evolution Model.Primary chemoprevention of breast cancer: Are the adverse effects too burdensome?Can the breast screening appointment be used to provide risk assessment and prevention advice?Acceptance and adherence to chemoprevention among women at increased risk of breast cancerChemoprevention for Breast Cancer.Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.Decision making for breast cancer prevention among women at elevated riskPreferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment.Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I).Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review.Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials.Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a "Traceback" approach.Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II.Deciding on breast cancer risk reduction: The role of counseling in individual decision-making - A qualitative study.Impact of NICE guidance on tamoxifen prescribing in England 2011-2017: an interrupted time series analysis.Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews.A highly fluorescent AIE-active theranostic agent with anti-tumor activity to specific cancer cells.Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
P2860
Q24185817-A2EB01F0-CA01-4439-9541-88DA55E99B4BQ26773464-B97614D9-DA7B-4583-BB5A-39A3E04960F5Q26774593-B76E87B3-6036-43FD-BF08-B8D3921F17B0Q28072526-22188145-9082-4E6E-99EF-DAA0A48BCC52Q30249199-8E890453-949E-4819-8961-9F01BD6C9DA4Q33561346-3876D7E7-3E0B-4955-B53D-423351B4E8ACQ35744037-8C7E8235-2603-4398-A675-841326CB0102Q35834376-951C4524-6059-40B0-9D41-67826E421B8EQ35854935-28373430-BA8F-4037-8A30-E9E7CAA45830Q35998680-3B0070D5-EF53-41DF-97EF-84C4F5EE4328Q36349610-70505223-B664-4FDE-A0E7-782816D62222Q37720955-82A70DD4-6F36-408A-ADBE-F96FE019F18DQ38669803-93727367-B7C2-433C-8D8C-860CC8B4F91DQ38702563-C500A41D-9B5A-4151-A753-BBC1FBD611A6Q41696217-C86869ED-B975-4AAC-86AA-B6335D13B0F3Q42372951-98E4EB85-81AA-4631-8DCB-8429BA36DDF0Q47386686-66D915B1-8FBD-4438-B645-BC1CD5249FBEQ48558036-D47D98F8-7848-40B7-9CA5-E97FE014A0AEQ51837751-DE686BAE-A6F4-486C-BBAB-51859998F0C7Q52571636-67874465-BC31-481B-9BC7-F0D19629B812Q52801719-93752749-256F-471D-A759-944E630FAE3BQ53175498-F4954AE0-7E50-4560-9E07-0F596F33776FQ55315231-4831CB67-936C-4A5D-9D16-A5EC1A9314BB
P2860
Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Uptake of tamoxifen in consecu ...... igh-risk breast cancer clinic.
@en
Uptake of tamoxifen in consecu ...... igh-risk breast cancer clinic.
@nl
type
label
Uptake of tamoxifen in consecu ...... igh-risk breast cancer clinic.
@en
Uptake of tamoxifen in consecu ...... igh-risk breast cancer clinic.
@nl
prefLabel
Uptake of tamoxifen in consecu ...... igh-risk breast cancer clinic.
@en
Uptake of tamoxifen in consecu ...... igh-risk breast cancer clinic.
@nl
P2093
P2860
P50
P356
P1476
Uptake of tamoxifen in consecu ...... high-risk breast cancer clinic
@en
P2093
L S Donnelly
P Stavrinos
R Greenhalgh
P2860
P2888
P304
P356
10.1038/BJC.2014.109
P407
P577
2014-03-04T00:00:00Z